Repligen (RGEN) has bought 908 Devices' (MASS) desktop portfolio for $70 million in cash, the companies said Tuesday.
The portfolio comprises four devices for bioprocessing process analytical technology applications, the companies added.
Repligen (RGEN) has bought 908 Devices' (MASS) desktop portfolio for $70 million in cash, the companies said Tuesday.
The portfolio comprises four devices for bioprocessing process analytical technology applications, the companies added.
Comments